Sat, 23/02/2008 - 00:00
The Medicines and Healthcare products Regulatory Agency is asking companies
that hold marketing authorisations for antidepressant medicines to
update their products’ warnings on suicidal thoughts and behaviour,
particularly with respect to the increased risk to young adults and
the need for close monitoring of patients.
Agreed wording for these warnings is available online.
